Role of endothelin in malignant hypertension
Krämer, B.K.; Riegger, G.A.
Clinical Nephrology 44(2): 136-137
1995
ISSN/ISBN: 0301-0430 PMID: 8529308 Document Number: 451106
Document emailed within 1 workday
Related Documents
Schiffrin, E.L. 1998: Endothelin: role in hypertension Biological Research 31(3): 199-208Yoshida, M.; Nonoguchi, H.; Owada, A.; Ishiyama, S.; Maeda, Y.; Ando, K.; Iwamoto, H.; Shiigai, T.; Marumo, F.; Tomita, K. 1994: Three cases of malignant hypertension: the roles of endothelin-1 and the renin-angiotensin-aldosterone system Clinical Nephrology 42(5): 295-299
Takayanagi, R.; Nawata, H. 1989: Role of endothelin in the development of hypertension Nihon Rinsho. Japanese Journal of Clinical Medicine 47(9): 1996-2002
Markewitz, B.A.; Kohan, D.E. 1995: Role of intrarenal endothelin in the generation and maintenance of hypertension Mineral and Electrolyte Metabolism 21(4-5): 342-352
Katona, E.; Juhász, M.ár.; Varga, Z.; Paragh, G.ör.; Fülesdi, B.él.; Páll, D.én. 2006: The role and clinical importance of nitric oxide-endothelin system in hypertension Orvosi Hetilap 147(38): 1819-1824
Siminiak, T.; Wysocki, H. 1994: Endothelin. II. The role of endothelin in the pathogenesis of disease Przeglad Lekarski 51(12): 527-530
Berthiaume, N.; Yanagisawa, M.; D'Orléans-Juste, P. 2000: Contribution of endogenous endothelin-1 and endothelin-A-receptors to the hypertensive state of endothelin-B heterozygous (+/-) knockout mice Journal of Cardiovascular Pharmacology 36(5 Suppl 1: S72-S74
Batyraliev, T.A.; Makhmutkhodzhaev, S.A.; Ekinsi, E.; Pataraia, S.A.; Pershukov, I.V.; Sidorenko, B.A.; Preobrazhenskiĭ, D.V. 2007: Pulmonary hypertension and right ventricular failure. Part XI. Endothelin receptor blockers in the treatment of primary pulmonary arterial hypertension Kardiologiia 47(7): 73-82
Gorbacheva, O.N.; Zharova, E.A.; Masenko, V.P.; Nasonov, E.L.; Samoriadova, O.S.; Karpov, I.A. 1991: Endothelin in arterial hypertension Terapevticheskii Arkhiv 63(4): 48-50
Yan, S.W. 1993: Plasma endothelin levels in pregnancy induced hypertension Zhonghua Fu Chan Ke Za Zhi 28(12): 709
Feng, T.; Yuan, H. 2001: Cytomegalovirus infection associated with plasma endothelin and P-selectin in patients with essential hypertension Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 15(4): 377-379
Yang, X.; Chen, W.; Chen, J. 1996: Changes on level and expression of endothelin-1 in the lungs of rats with hypoxic pulmonary hypertension Zhonghua Nei Ke Za Zhi 35(11): 734-737
Yang, Z.; Wang, S. 1998: Relationship between nitric oxide synthase, endothelin and the initiation of hypertension and atherosclerosis Hua Xi Yi Ke da Xue Xue Bao 29(2): 160-164
Kanno, K.; Hirata, Y. 2004: Involvement of endothelin in the pathogenesis of hypertension and hypertensive target-organ damage Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 3): 164-168
Müller, D.N.; Fiebeler, A.; Park, J.K.; Dechend, R.; Luft, F.C. 2003: Angiotensin Ii and endothelin induce inflammation and thereby promote hypertension-induced end-organ damage Clinical Nephrology 60(Suppl 1): S2-12
Cichocka, E. 1995: Physiologic and pathophysiologic role of endothelin Pediatria Polska 70(2): 103-108
Endo, M.; Goto, K. 1997: Role of endothelin in cardiovascular regulation Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 110(3): 116-119
Agapitov, L.I.; Belozerov, I.M.; Mizernitskiĭ, I.L. 2012: The endothelin-1 and von Willebrand factor in the development of lung hypertension in children with chronic bronchopulmonary pathology Klinicheskaia Laboratornaia Diagnostika 1: 11-13
Fomin, V.V.; Popova, E.N.; Kuznetsova, A.V.; Popova, I.A.; Churganova, L.I.; Osipenko, V.I.; Mukhin, N.A. 2009: Endothelin-1 and brain natriuretic peptide in the development of pulmonary hypertension in interstitial lung diseases Terapevticheskii Arkhiv 81(12): 58-63
Shalev, L.; Langevitz, P.; Zandman-Goddard, G. 2008: Long-term therapy with endothelin-1 antagonist for pulmonary hypertension secondary to systemic sclerosis Harefuah 147(4): 287-289; 376